Workflow
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance
CLOVClover Health Investments(CLOV) GlobeNewswire·2025-02-27 21:05

Full year 2024 GAAP Net loss from continuing operations improves by 164millionyear−over−yearFullyear2024AdjustedEBITDAof164 million year-over-year Full year 2024 Adjusted EBITDA of 70 million, representing an increase of 112millionyear−over−yearCompanywellpositionedtoinvestinmembershipgrowthandCloverAssistanttechnology,whilemaintainingstrongprofitabilityIssuesfullyear2025guidance:AverageMedicareAdvantagemembershipof103,000−107,000,representing30112 million year-over-year Company well positioned to invest in membership growth and Clover Assistant technology, while maintaining strong profitability Issues full year 2025 guidance: Average Medicare Advantage membership of 103,000 - 107,000, representing 30% growth year-over-year at the midpointInsurance revenue between 1.800 billion ...